LINC-PINT and colon adenocarcinoma: The results showed that COAD patients with different expressions of LINC-PINT have apparent differences in sensitivity to various chemotherapeutic drugs, particularly patients whose tumors exhibit low LINC-PINT expression are more sensitive to chemotherapy.